Placental tissue grafts and methods of preparing and using the same

• US 9,084,767 B2
• Filed: 07/03/2014
• Issued: 07/21/2015
• Est. Priority Date: 09/07/2007
• Status: Active Grant

• Current Assignee: Mimedx Group Incorporated
• Original Assignee: Mimedx Group Incorporated
• Inventors: Daniel, John, Spencer, Randall, Russo, John, Tofe, Robert
• Primary Examiner(s): FOX, ALLISON M
• Application Number:
  US14/323,964
• Publication Number:
  US 20140322289A1
• Time in Patent Office: 383 Days
• Field of Search: None
• US Class Current: 1/1
• CPC Class Codes: A61F 2210/00 Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
• CPC Class Codes: A61F 2230/00 Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
• CPC Class Codes: A61K 35/19 Platelets; Megacaryocytes
• CPC Class Codes: A61K 35/28 Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
• CPC Class Codes: A61K 35/33 Fibroblasts
• CPC Class Codes: A61K 35/50 Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
• CPC Class Codes: A61L 2430/34 for soft tissue reconstruction
• CPC Class Codes: A61L 2430/40 Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
• CPC Class Codes: A61L 27/3604 characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
• CPC Class Codes: A61L 27/3683 subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
• CPC Class Codes: A61L 27/3834 Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
• CPC Class Codes: A61L 27/56 Porous materials, e.g. foams or sponges
• CPC Class Codes: A61P 41/00 Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
• CPC Class Codes: Y10T 156/10 Methods of surface bonding and/or assembly therefor
• CPC Class Codes: Y10T 156/1039 Surface deformation only of sandwich or lamina [e.g., embossed panels]

Abstract

Described herein are tissue grafts derived from the placenta. The grafts are composed of at least one layer of amnion tissue where the epithelium layer has been substantially removed in order to expose the basement layer to host cells. By removing the epithelium layer, cells from the host can more readily interact with the cell-adhesion bio-active factors located onto top and within of the basement membrane. Also described herein are methods for making and using the tissue grafts. The laminin structure of amnion tissue is nearly identical to that of native human tissue such as, for example, oral mucosa tissue. This includes high level of laminin-5, a cell adhesion bio-active factor show to bind gingival epithelia-cells, found throughout upper portions of the basement membrane.

Claims

1. A tissue graft comprising:

a first membrane comprising modified amnion wherein the modified amnion has a first side which is an exposed basement membrane and a second side which is a fibroblast layer; and

one or more additional membranes laminated to the first membrane,

wherein the one or more additional membranes is selected from the group consisting of amnion, chorion, allograft pericardium, allograft acellular dermis, amniotic membrane, Wharton'"'"'s jelly, and combinations thereof, and

wherein the first membrane and the one or more additional membranes of the tissue graft are not held in together with a suture.

2. The graft of claim 1, wherein the one or more additional membranes is selected from the group consisting of amnion, chorion, or a combination thereof.

3. The graft of claim 1, wherein the one or more additional membranes are two amnion membranes layered to the first membrane.

4. The graft of claim 1, wherein the one or more additional membranes are four amnion membranes layered to the first membrane.

5. The graft of claim 1, wherein a bioactive agent selected from the group consisting of a naturally occurring growth factor, a platelet concentrate, a bone marrow aspirate, stem cells, and/or an antibiotic is absorbed into the first membrane and/or the one or more additional membranes.

6. The graft of claim 1, wherein the number of membranes layered to the first membrane is from 1 to 10.

7. The graft of claim 1, wherein the graft has a thickness from 0.2 mm to 10 mm.

8. The graft of claim 1, wherein the graft has a plurality of holes penetrating the graft.

9. The graft of claim 1, wherein up to five additional membranes are laminated to the first membrane.

10. The graft of claim 1, wherein up to ten additional membranes are laminated to the first membrane.